Terms: = Bone cancer AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE AND Staging
3 results:
1. Radioisotope-guided Lymphadenectomy for Pelvic Lymph Node staging in Patients With Intermediate- and High-risk Prostate cancer (The Prospective SENTINELLE Study).
Lannes F; Baboudjian M; Ruffion A; Rouy M; Giammarile F; Rousseau T; Kraeber-Bodéré F; Rousseau C; Rusu D; Colombié M; Brenot-Rossi I; Rossi D; Mottet N; Bastide C
J Urol; 2023 Feb; 209(2):364-373. PubMed ID: 36331157
[TBL] [Abstract] [Full Text] [Related]
2. Diagnostic value of
Nguyen A; Fullard K; Sheehan-Dare G; Tang R; Chan L; Ho B; Dear R; Keane J; Hickey A; Nandurkar R; Chen J; Chen A; Lim E; Emmett L
J Med Imaging Radiat Oncol; 2022 Sep; 66(6):731-737. PubMed ID: 34676675
[TBL] [Abstract] [Full Text] [Related]
3. Importance of non-regional lymph nodes in assigning risk in primary metastatic prostate cancer.
Ali A; Hoyle A; Mistry H; Clarke NW
BJU Int; 2019 Jan; 123(1):65-73. PubMed ID: 29777564
[TBL] [Abstract] [Full Text] [Related]
